Yahoo Web Search

Search results

    • Q1 2024 Viridian Therapeutics Inc Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 10 hours ago

      We see opportunity for us to provide differentiated options for TED patients with both our IV and subcu programs because TED is an autoimmune disease characterized ...